In accordance with these data, ablation of SNAT1 was reported to decrease cell proliferation and migration in melanoma and gastric cancer cell models, evidencing that SNAT1 might play an important role in the maintenance of the malignant phenotype [61,62]. This evidence concerns the gene SLC38A1 and gastric cancer.